JPRN-UMIN000002000
Completed
Phase 2
A randomized phase II trial of adjuvant Chemotherapy with Gemcitabine alone, S-1 alone, versus gemcitabine and S-1 in patients with resected pancreatic cancer - CAP-002
Chiba study group of adjuvant chemotherapy for pancreatic cancer0 sites96 target enrollmentMay 25, 2009
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Incasive ductal carcinoma of pancreas with macroscopic complete resection
- Sponsor
- Chiba study group of adjuvant chemotherapy for pancreatic cancer
- Enrollment
- 96
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Inadequate physical condition for gemcitabine or S\-1 treatmetn according to manufacture's instruction 2\. With pulmonary fibrosis or interstitial pneumonia 3\. Massive pleural effusion 4\. With distant metastasis 5\. Active malignancies other than pancreatic cancer 6\. Active infectious disease 7\. Severe post operative complications 8\. Severe angina, cardiac infurction within 3 months at the registration, and severe hear failure 9\. Severe diabetes or hypertension 10\. Severe mental disorder 11\. Pregnancy, breast feeding, or women who desire to preserve fecundity 12\. Inadequate physical condition, as diagnosed by primary physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A randomized phase II trial of adjuvant chemotherapy with UFT/LV versus S-1 following curative resection for stage III colorectal cancerstage III colorectal cancerJPRN-UMIN000001560Boso Clinical Oncology Group140
Recruiting
Phase 2
A phase II randomized trial of adjuvant chemotherapy for the patients completely resected pathological stage IB(T>5cm), II, IIIA Non Small Cell Lung Cancer comparing S-1 / S-1 with CDDPnon-small cell lung cancerJPRN-UMIN000001765Kyushu University,Graduate School of Medical Science,Department of Surgery and Science140
Recruiting
Phase 2
Randomized phase II trial of neoadjuvant Chemotherapy with Gemcitabine and S-1 vs. without neoadjuvant chemotherapy in patients with resectable pancreatic cancerResectable pancreatic cancerJPRN-UMIN000009822Chiba study group of adjuvant chemotherapy for pancreatic cancer74
Active, not recruiting
Phase 1
Bintrafusp alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma.retroperitoneal sarcomasMedDRA version: 20.0Level: LLTClassification code 10039494Term: Sarcoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10077289Term: Retroperitoneal sarcomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2021-001085-37-FRInstitut Bergonié66
Completed
Not Applicable
Randomized phase II study of neoadjuvant chemotherapy with or without letrozole for postmenopausal ER-positive/HER2-negative breast cancersPostmenopausal breast cancerJPRN-UMIN000008416Kobe Breast Cancer Oncology Group70